logo dark logoo light logo
  • Platform
  • Pipeline
  • About Us
    • About Us
    • Meet the Team
  • Investors
    • Board of Directors
    • SEC Filings
    • Investor FAQ
  • News
  • Contact
logo dark logoo light logo
  • Platform
  • Pipeline
  • About Us
    • About Us
    • Meet the Team
  • Investors
    • Board of Directors
    • SEC Filings
    • Investor FAQ
  • News
  • Contact
mobile logo
  • Platform
  • Pipeline
  • About Us
    • About Us
    • Meet the Team
  • Investors
    • Board of Directors
    • SEC Filings
    • Investor FAQ
  • News
  • Contact
ProLung announces corporate name change to IONIQ Sciences to reflect expanded early cancer detection strategy
In News

Salt Lake City, UT, May 27, 2020 – IONIQ Sciences Inc. (“IONIQ Sciences” or the...

Read More
ProLung Announces Fully Subscribed Private Placement of $3.3 Million
In News

Salt Lake City, UT, May 22, 2020 – ProLung, Inc. (“ProLung” or the “Company”), which has...

Read More
ProLung, Inc. Called One of the “50 Most Innovative Companies to Watch in 2020” by CEO Views
In Awards and Recognition

ProLung, Inc. is proud to announce it is one of the “50 Most Innovative Companies...

Read More
ProLung Test is honored as “Most Innovative Non-Invasive Lung Cancer Testing Solution 2020” by Global Health & Pharma
In Awards and Recognition, News

ProLung has been awarded the “Most Innovative Non-Invasive Lung Cancer Testing Solution 2020” by Global...

Read More
In Their Words: Jared Bauer
In Awards and Recognition, News

In Their Words: Jared Bauer Utah has an incredibly strong life sciences community with a rich...

Read More
ProLung Test Granted ‘Breakthrough Device’ Designation by the FDA
In Awards and Recognition, News

ProLung Test Granted ‘Breakthrough Device’ Designation by the FDA Salt Lake City, UT, February 13, 2020...

Read More
ProLung Announces End of 2012-2014 Governance Issues
In News

ProLung Announces End of 2012-2014 Governance Issues Salt Lake City, UT, February 13, 2020 – ProLung,...

Read More
CEO Today Magazine Honors ProLung CEO Jared Bauer for Leadership and Strategic Vision in 2019
In Awards and Recognition, News

We are delighted to share that Jared Bauer, ProLung CEO, has been honored for his...

Read More
ProLung Announces Change to its Board of Directors
In News

ProLung Announces Change to its Board of Directors Salt Lake City, UT, November 26, 2019 –...

Read More
ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer solution pursuing FDA clearance at ISRD & ATS joint medical conference
In News

ProLung, Inc. presents highest combined sensitivity and specificity values for a truly non-invasive lung cancer...

Read More
ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 74% specificity
In News

ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 73% specificity Salt Lake...

Read More
ProLung Promotes Jared Bauer from interim CEO to CEO
In News

ProLung Promotes Jared Bauer from interim CEO to CEO Salt Lake City, UT, October 2, 2019...

Read More
  • 1
  • 2
  • 3
  • 4
  • 5

Categories

  • Awards and Recognition
  • News

Search

Latest News

  • IONIQ awarded 2020 Business Excellence Award by Silicon Review 01/20/2021
  • IONIQ Sciences Designated ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine 12/10/2020
  • IONIQ Sciences Joins Newly Formed BioHive 11/09/2020

Archive

  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • May 2020
  • April 2020
  • February 2020
  • January 2020
  • November 2019
  • October 2019
  • August 2019
  • July 2019
  • June 2019
  • March 2019
  • February 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • December 2017
  • May 2017
cancer testing modernized

Not available for sale in the USA

Latest News

  • IONIQ awarded 2020 Business Excellence Award by Silicon Review
  • IONIQ Sciences Designated ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine
  • IONIQ Sciences Joins Newly Formed BioHive
  • IONIQ Sciences Recognized with 2020’s “Most Innovative Non-Invasive Lung Cancer Testing Solution” by Global 100

Twitter Feed

  • We’ve been awarded the 2020 Business Excellence Award by Silicon Review. Our ‘FDA breakthrough’ electrical impedanc… https://t.co/JwIa8Zt0wm
    3 days ago
  • We're glad to be recognized by CV magazine for our ongoing efforts to modernize cancer testing. We've achieved exci… https://t.co/CCBItrEdPl
    1 month ago
  • Did you know exposure to radon gas is the 2nd-leading cause of lung cancer in the USA? Only 12% of homes in Utah ha… https://t.co/n4e6T2pMy6
    2 months ago

Subscribe to our Newsletter

ProLung, Inc. dba IONIQ Sciences Copyright 2020. All Rights Reserved - Privacy Policy - Terms and Conditions